| Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting M Al-Azab, M Safi, E Idiiatullina, F Al-Shaebi, MY Zaky Cellular & Molecular Biology Letters 27 (1), 69, 2022 | 53 | 2022 |
| PD-1/PDL-1 inhibitors and cardiotoxicity; molecular, etiological and management outlines M Safi, H Ahmed, M Al-Azab, Y Xia, X Shan, M Al-Radhi, A Al-Danakh, ... Journal of Advanced Research 29, 45-54, 2021 | 35 | 2021 |
| Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries JC Glasbey, TEF Abbott, A Ademuyiwa, A Adisa, E AlAmeer, S Alshryda, ... The Lancet 400 (10363), 1607-1617, 2022 | 27 | 2022 |
| Posterior tibial nerve stimulation for overactive bladder: mechanism, classification, and management outlines A Al-Danakh, M Safi, M Alradhi, M Almoiliqy, Q Chen, M Al-Nusaif, X Yang, ... Parkinson’s Disease 2022 (1), 2700227, 2022 | 17 | 2022 |
| Molecular mechanisms of anticancer activities of polyphyllin VII B Ahmad, SU Rehman, A Azizullah, MF Khan, SRU Din, M Ahmad, A Ali, ... Chemical Biology & Drug Design 97 (4), 914-929, 2021 | 17 | 2021 |
| Integrated Chinese herbal medicine with Western Medicine versus Western Medicine in the effectiveness of primary hypertension treatment: A systematic review and meta-analysis … SAD Mohammed, L Hanxing, L Fang, AM Algradi, M Alradhi, M Safi, ... Journal of ethnopharmacology 300, 115703, 2023 | 14 | 2023 |
| Downregulated ARID1A by miR-185 is associated with poor prognosis and adverse outcomes in colon adenocarcinoma S Baldi, H Khamgan, Y Qian, H Wu, Z Zhang, M Zhang, Y Gao, M Safi, ... Frontiers in oncology 11, 679334, 2021 | 11 | 2021 |
| Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study M Safi, M Al-Azab, C Jin, D Trapani, S Baldi, S Adlat, A Wang, B Ahmad, ... Frontiers in Immunology 12, 609728, 2021 | 9 | 2021 |
| Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study M Alradhi, M Safi, S Tao, A Al-Danakh, M Almoiliqy, S Baldi, X Li Therapeutic advances in urology 14, 17562872221079473, 2022 | 8 | 2022 |
| Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells A Shopit, X Li, S Wang, M Awsh, M Safi, P Chu, J Jia, M Al-Radhi, S Baldi, ... Phytomedicine 91, 153711, 2021 | 6 | 2021 |
| Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?: A prospective comparative study MA Al-Radhi, LK Lun, M Safi, A Al-Danakh, KM Al-Kohlany, A Al-Najar, ... Medicine 100 (20), e25745, 2021 | 6 | 2021 |
| Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies E Qaed, B Al-Hamyari, A Al-Maamari, A Qaid, H Alademy, M Almoiliqy, ... Global Medical Genetics 10 (03), 205-220, 2023 | 5 | 2023 |
| Immune checkpoint inhibitor (ICI) genes and aging in clear cell renal cell carcinoma (ccRCC): Clinical and genomic study A Al-Danakh, M Safi, M Alradhi, Q Chen, S Baldi, X Zhu, D Yang Cells 11 (22), 3641, 2022 | 5 | 2022 |
| Heterozygous loss of Dip2B enhances tumor growth and metastasis by altering immune microenvironment S Adlat, F Hayel, Y Chen, RK Sah, ZM Oo, M Al-Azab, MZZ Myint, ... International Immunopharmacology 105, 108559, 2022 | 5 | 2022 |
| Risk of Rash in PD‐1 or PD‐L1‐Related Cancer Clinical Trials: A Systematic Review and Meta‐Analysis Y Tian, C Zhang, Q Dang, K Wang, Q Liu, H Liu, H Shang, J Zhao, Y Xu, ... Journal of Oncology 2022 (1), 4976032, 2022 | 5 | 2022 |
| Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study. Front M Safi, R Kanesvaran, M Alradhi, A Al-Danakh, F Ping, N Al-Sabai, ... Oncol 10, 572380, 2020 | 5 | 2020 |
| Enhancers of mesenchymal stem cell stemness and therapeutic potency M Al-Azab, E Idiiatullina, M Safi, K Hezam Biomedicine & Pharmacotherapy 162, 114356, 2023 | 4 | 2023 |
| Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study M Safi, C Jin, A Aldanakh, P Feng, H Qin, M Alradhi, L Zhang, J Zhang, ... BMC cancer 22 (1), 978, 2022 | 4 | 2022 |
| Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer F Alshaebi, M Safi, YA Algabri, M Al-Azab, A Aldanakh, M Alradhi, ... Frontiers in Oncology 13, 1099696, 2023 | 3 | 2023 |
| ANCA-Associated vasculitis: advancement in pathogenesis, clinical features and management M Al Azab, M Safi, B Wang Biomedical Journal of Scientific & Technical Research 21 (2), 15813-15819, 2019 | 3 | 2019 |
